TM
Timothy P. Moran
Chief Business Officer

Timothy P. Moran insider trades: Kestra Medical Technologies (KMTS) stock buys and sales

Chief Business Officer, Kestra Medical Technologies Last trade Nov 3, 2026 21 Form 4 filings
$443K
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2018
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Timothy reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 3, 2026KMTS↓ Sell$94K
Aug 3, 2026KMTS↓ Sell$348K
Nov 19, 2021MOTS↑ Buy$5K
Dec 4, 2020MOTS↑ Buy$10K
Nov 20, 2019MOTS↑ Buy$15K
Jul 1, 2019MOTS↑ Buy$10K
May 22, 2019MOTS↑ Buy$17K
Dec 24, 2018MOTS↑ Buy$27K
Nov 19, 2018MOTS↑ Buy$52K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other KMTS insiders

Open-market trades in the last 12 months

About Timothy P. Moran's insider trades

Timothy P. Moran is Chief Business Officer at Kestra Medical Technologies (KMTS). Since Nov 19, 2018, Timothy has reported 7 open-market purchases worth $136K and 2 sales worth $443K on SEC Form 4. In the last 12 months: 2 sales ($443K).

Their filings also include grants and awards (12 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KMTS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.